228 related articles for article (PubMed ID: 15164305)
1. Treatment strategies for uterine leiomyoma: the role of hormonal modulation.
Cook JD; Walker CL
Semin Reprod Med; 2004 May; 22(2):105-11. PubMed ID: 15164305
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma.
Walker CL; Burroughs KD; Davis B; Sowell K; Everitt JI; Fuchs-Young R
J Soc Gynecol Investig; 2000; 7(4):249-56. PubMed ID: 10964025
[TBL] [Abstract][Full Text] [Related]
3. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
4. Fibroids: pathophysiology and current medical treatment.
Nowak RA
Baillieres Best Pract Res Clin Obstet Gynaecol; 1999 Jun; 13(2):223-38. PubMed ID: 10755039
[TBL] [Abstract][Full Text] [Related]
5. Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma.
Walker CL
Recent Prog Horm Res; 2002; 57():277-94. PubMed ID: 12017548
[TBL] [Abstract][Full Text] [Related]
6. [GnRH agonists and antagonists in the preoperative therapy of uterine fibroids: literature review].
De Falco M; Pollio F; Pontillo M; Ambrosino E; Busiello A; Carbone IF; Ciociola F; Di Nardo MA; Landi L; Di Lieto A
Minerva Ginecol; 2006 Dec; 58(6):553-60. PubMed ID: 17108883
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
8. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
Lewis JS; Jordan VC
Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
[TBL] [Abstract][Full Text] [Related]
9. Role of Medical Management for Uterine Leiomyomas.
Kashani BN; Centini G; Morelli SS; Weiss G; Petraglia F
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():85-103. PubMed ID: 26796059
[TBL] [Abstract][Full Text] [Related]
10. [Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].
Maeda T; Ke HZ; Simmons H; Thompson D
Clin Calcium; 2004 Oct; 14(10):85-93. PubMed ID: 15577137
[TBL] [Abstract][Full Text] [Related]
11. Medical management of fibroids.
Sankaran S; Manyonda IT
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
[TBL] [Abstract][Full Text] [Related]
12. Potential nonhormonal therapeutics for medical treatment of leiomyomas.
Young SL; Al-Hendy A; Copland JA
Semin Reprod Med; 2004 May; 22(2):121-30. PubMed ID: 15164307
[TBL] [Abstract][Full Text] [Related]
13. Shrinkage effect of gonadotropin releasing hormone agonist treatment on uterine leiomyomas and t(12;14).
Takahashi K; Kawamura N; Ishiko O; Ogita S
Int J Oncol; 2002 Feb; 20(2):279-83. PubMed ID: 11788889
[TBL] [Abstract][Full Text] [Related]
14. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
Lethaby AE; Vollenhoven BJ
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
[TBL] [Abstract][Full Text] [Related]
15. [Gonadotropin-releasing hormone analogs].
Krysiak R; Okopień B; Herman ZS
Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
[TBL] [Abstract][Full Text] [Related]
16. Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens.
Hansen LM; Batzer FR; Corson SL; Bello S
J Reprod Med; 1997 Apr; 42(4):247-50. PubMed ID: 9131500
[TBL] [Abstract][Full Text] [Related]
17. Selective estrogen receptor modulator and selective progesterone receptor modulator: therapeutic efficacy in the treatment of uterine leiomyoma.
Ohara N
Clin Exp Obstet Gynecol; 2005; 32(1):9-11. PubMed ID: 15864926
[TBL] [Abstract][Full Text] [Related]
18. The GnRH agonists in the treatment of uterine leiomyomas.
Bianchi S; Fedele L
Acta Eur Fertil; 1989; 20(1):5-10. PubMed ID: 2675524
[TBL] [Abstract][Full Text] [Related]
19. Fibroid growth and medical options for treatment.
Chabbert-Buffet N; Esber N; Bouchard P
Fertil Steril; 2014 Sep; 102(3):630-9. PubMed ID: 25171950
[TBL] [Abstract][Full Text] [Related]
20. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
Kastelan D; Giljevic Z; Kraljevic I; Korsic M
Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
